M.FARUK KOSE

• 2011Medical Specialization Board Gynecological Oncology Surgery
• 1988Ankara University Faculty of Medicine, Department of Obstetrics and Gynaecology
• 1981Hacettepe University Faculty of Medicine

Experience

• 2020Acıbadem Health Group
• 2014 – 2016Medipol Mega University Hospital / Obstetrics and Gynecology / Gynecological Oncology Surgery Specialist
• 2012 – 2014LIV Hospital Ulus / Gynecology and Obstetrics Clinic Director
• 2011 – 2012Universal Italian Giovanni Alberto Agnelli Hospital / Medical Director
• 2005 – 2011Etlik Zübeyde Hanım Gynecology and Obstetrics Training and Research Hospital, Gynecological Oncology Clinic / Clinic Chief
• 1992 – 2005Ankara Maternity and Gynecology Training Hospital Gynecological Oncology Clinic / Clinic Chief
• 1988 – 1992Ankara Maternity and Gynecology Training Hospital / Specialist Physician
• 1981 – 1983Ankara Sugar Factory / General Practitioner

• European Society of Gynaecological Oncology
• Senalogy Academy
• Society of Gynecologic Oncology
• South Eastern European Robotic Surgery Society
• Minimally Invasive Gynecologic Oncology Association
• New European Surgical Academy
• Cervical Pathology and Colposcopy Association
• Turkish Obstetrics and Gynecology Association
• Turkish Gynecological Oncology Association
• Middle East and Mediteranean Association of Gynecologic Oncologist
• Society of Robotic Gynecological Surgery
• Turkish German Gynecology Education, Research and Service Foundation
• Turkish Medical Association
• International Gynecologic Cancer Society
• Trophoblastic Diseases Association
• Society of European Robotic Gynecologic Surgery

• Prognostic Factors in Adult Granulosa Cell Tumor: A Long Follow-Up at a Single Center.Int J Gynecol Cancer. 2016 May;26(4):619-25. Karalok A, Turan T, Ureyen I, Tasci T, Basaran D, Koc S, Boran N, Kose MF, Tulunay G
• Management of cervical cancer during pregnancy.J Obstet Gynaecol. 2016 Apr;36(3):366-71. Gungorduk K, Sahbaz A, Ozdemir A, Gokcu M, Sancı M, Köse MF.
• Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer.Pathol Oncol Res. 2015 Jul;21(3):803-10. Alay I, Turan T, Ureyen I, Karalok A, Tasci T, Ozfuttu A, Kose MF, Tulunay G.
• Malignant transformation of mature cystic teratoma of the ovary: a case series.J Exp Ther Oncol. 2015;11(1):11-6. Koc S, Tapisiz OL, Turan T, Ocalan R, Ozfuttu A, Boran N, Kose MF, Tulunay HG.
• Clinical outcomes of uterine carcinosarcoma: results of 94 patients.Int J Gynecol Cancer. 2015 Feb;25(2):279-87. Gokce ZK, Turan T, Karalok A, Tasci T, Ureyen I, Ozkaya E, Kose MF, Tulunay G.
• Early and Late Complications after Inguinofemoral Lymphadenectomy for Vulvar Cancer.Asian Pac J Cancer Prev. 2015;16(13):5175-9. Cirik DA, Karalok A, Ureyen I, Tasci T, Kalyoncu R, Turkmen O, Kose MF, Tulunay G, Turan T.
• Does Lymphadenectomy Improve Survival in Uterine Leiomyosarcoma?Int J Gynecol Cancer. 2015 Jul;25(6):1031-6. Tasci T, Karalok A, Taskin S, Ureyen I, Kımyon G, Tulek F, Ozfuttu A, Turan T, Tulunay G, Kose MF, Ortac F.
• Risk for malignant and borderline ovarian neoplasms following basic preoperative evaluation by ultrasonography, Ca125 level and age.Asian Pac J Cancer Prev. 2014;15(19):8489-93. Karadag B, Kocak M, Kayikcioglu F, Ercan F, Dilbaz B, Kose MF, Haberal A.
• Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy -a retrospective evaluation.Turk J Med Sci. 2014;44(2):212-9. Ozgul N, Kose MF, Keskin HL, Turan AT, Karalok MA, Ureyen I, Borani N, Tulunay HG.
• What is the importance of omental metastasis in patients with endometrial cancer?J Turk Ger Gynecol Assoc. 2014 Aug 8;15(3):164-72. Turan T, Ureyen I, Karalök A, Taşçı T, Ilgın H, Keskin L, Kose MF, Tulunay G.